♟️ Tuesday 16 June 2026 Tue, 16 June 2026

Island Pharmaceuticals has presented encouraging Phase 2a results for its dengue antiviral ISLA-101, demonstrating safety, effective blood concentrations, and meaningful viral load reductions at the Asia Dengue Summit.

Amara Minerals has raised $2.2 million through a placement priced 25% above its last trade, with cornerstone investor Nova Minerals increasing its holding by $500,000. The funds will accelerate drilling at Victorian gold-antimony projects following promising assay results.

Amara Minerals secured a $2.2 million placement at a 25% premium, with Nova Minerals increasing its strategic investment by $500,000. Meanwhile, Nova Minerals completed its redomiciliation to the US, listing on NYSE American and delisting from ASX.

Qube Holdings shareholders convened to endorse a $5.20 per share acquisition scheme by Rubik Australia, valuing the logistics firm at $9.3 billion equity and $11.7 billion enterprise value. The deal awaits key regulatory approvals and a rescheduled court hearing before implementation.

Delta Lithium Limited has acquired key tenements at its Yinnetharra Project, gaining full control over 170 km2 of lithium prospective ground. The company also reports a notable gold occurrence at Mason’s prospect and continues extensive exploration across its large tenure.

Centuria Capital Group unveils a vertically integrated AI and data centre strategy through its partnership with ResetData, aiming to capture surging sovereign AI demand amid global supply constraints.

Cobalt Blue Holdings and Glomar Minerals have shortlisted four US sites and begun testwork for Project Infinity, aiming to build the first commercial polymetallic nodule refinery in the United States.

Galilee Energy is gearing up to drill its Zydeco-1 well in Louisiana this July, aiming to kickstart near-term cash flow from a low-cost, low-risk gas-condensate project. The company’s newly formed US advisory board supports a strategy to scale production through repeatable Gulf Coast asset acquisitions.

InteliCare (ASX:ICR) is hitting a commercial inflection point, backed by a landmark $8.8 million contract with mecwacare and a growing pipeline across aged care sectors. Its AI-powered platform promises measurable improvements in care outcomes and operational efficiency.

TradeWindow Holdings has appointed Dewald van Rensburg as permanent CEO, endorsing his leadership following a transitional period after the previous CEO's resignation.